Skip to main content

Advertisement

Log in

Reappraisal of clinical indication regarding total pancreatectomy: can we do it for the risky gland?

  • Original Article
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Background

Although total pancreatectomy (TP) is performed at an increasing rate at major pancreatic centers, there is still debate regarding its indications and outcomes. This study aims to analyze the indications and outcomes of TP using our retrospective data.

Methods

We conducted a retrospective study on patients who underwent TP between January 2009 and December 2019 at two academic hospitals using data collected. Preoperative data, including demographics and clinical picture, operative details, and postoperative data, were collected and analyzed. Conventional indications of TP included positive margin on the neck, lesion of the central part of the pancreas, and diffuse lesions of the whole pancreas. The classification of the risky gland included pancreas remnants, which had higher risk for pancreaticoenterostomy after pancreatic head resection.

Results

During the study periods, a total of 72 TP were performed for benign and malignant pancreatic diseases. After excluding six TP undergone due to trauma or complication after partial pancreatectomy, 64 patients were grouped into 47 patients with existing conventional indications and 17 patients with predicted risky anastomosis. There was no significant difference in clinical data and surgical results between the conventional indication group and the risky gland group. Thirty-day major morbidity and mortality was 9.4% and 0%, respectively. Ninety-day mortality rate was 1.4% (n=1, conventional group), with the median follow-up length of 21.5 months. Overall 5-year survival rate was 67.7% for the total participants: 87.5% for the risk gland group and 57.9% for the conventional group. There was no significant difference in between the two groups.

Conclusions

Total pancreatectomy appears to be a viable option for risky glands in terms of surgical safety.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Howard JM, Jordan GL (1960) Surgical disease of the pancreas. JB Lippincott, Philadelphia, PA

    Google Scholar 

  2. Dresler CM, Fortner JG, McDermott K et al (1991) Metabolic consequences of (regional) total pancreatectomy. Ann Surg 214:131–140

    Article  CAS  Google Scholar 

  3. Grace PA, Pitt HA, Tompkins RK, DenBesten L, Longmire WP Jr (1986) Decreased morbidity and mortality after pancreatoduodenectomy. Am J Surg 151:141–149

    Article  CAS  Google Scholar 

  4. Janot MS, Belyaev O, Kersting S et al (2010) Indications and early outcomes for total pancreatectomy at a high-volume pancreas center. HPB Surg 2010:686702

    Article  Google Scholar 

  5. Kulu Y, Schmied BM, Werner J et al (2009) Total pancreatectomy for pancreatic cancer: indications and operative technique. HPB (Oxford) 11:469–475

    Article  Google Scholar 

  6. Heidt DG, Burant C, Simeone DM (2007) Total pancreatectomy: indications, operative technique, and postoperative sequelae. J Gastrointest Surg. 11:209–216

    Article  Google Scholar 

  7. Hartwig W, Gluth A, Hinz U et al (2015) Total pancreatectomy for primary pancreatic neoplasms: renaissance of an unpopular operation. Ann Surg 261:537–546

    Article  Google Scholar 

  8. Balzano G, Maffi P, Nano R et al (2015) Autologous islet transplantation in patients requiring pancreatectomy: a broader spectrum of indications beyond chronic pancreatitis. Am J Transplant 16:1812–1826

    Article  Google Scholar 

  9. Del Chiaro M, Rangelova E, Segersvärd R, Arnelo U (2016) Are there still indications for total pancreatectomy? Updates Surg 68(3):257–263

    Article  Google Scholar 

  10. Aiocchi GL, Portolani N, Missale G et al (2010) Intraductal papillary mucinous neoplasm of the pancreas (IPMN): clinico-pathological correlations and surgical indications. World J Surg Oncol 8:25

    Article  Google Scholar 

  11. Almond M, Roberts KJ, Hodson J et al (2015) Changing indications for a total pancreatectomy: perspectives over a quarter of a century. HPB (Oxford) 17:416–421

    Article  Google Scholar 

  12. Stauffer JA, Nguyen JH, Heckman MG et al (2009) Patient outcomes after total pancreatectomy: a single centre contemporary experience. HPB (Oxford) 11:483–492

    Article  Google Scholar 

  13. Reddy S, Wolfgang CL, Cameron JL et al (2009) Total pancreatectomy for pancreatic adenocarcinoma: evaluation of morbidity and long-term survival. Ann Surg 250:282–287

    Article  Google Scholar 

  14. Pulvirenti A, Pea A, Rezaee N et al (2019) Perioperative outcomes and long-term quality of life after total pancreatectomy. Br J Surg 106:1819–1828

    Article  CAS  Google Scholar 

  15. Crippa S, Tamburrino D, Partelli S et al (2011) Total pancreatectomy: indications, different timing, and perioperative and long-term outcomes. Surgery 149:79–86

    Article  Google Scholar 

  16. Casadei R, Ricci C, Taffurelli G et al (2015) Are there preoperative factors related to a “soft pancreas” and are they predictive of pancreatic fistulas after pancreatic resection? Surg Today 45:708–714

    Article  Google Scholar 

  17. Tranchart H, Gaujoux S, Rebours V et al (2012) Preoperative CT scan helps to predict the occurrence of severe pancreatic fistula after pancreaticoduodenectomy. Ann Surg 256:139–145

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Conception or design of the work: KYP; acquisition, analysis, or interpretation of data for the work: KYP, JCC; drafting the work: KYP, JCC; revising it critically for important intellectual content: KYP; final approval: KYP, JCC

Corresponding author

Correspondence to Kwang Yeol Paik.

Ethics declarations

Ethics approval

This study was approved by the Institutional Review Board of Soon Chun Hyang University, Bucheon Hospital and The Catholic University, Yeouido St. Mary’s Hospital, Republic of Korea. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Consent to participate

The need for informed consent was waived because this was a retrospective chart review analysis.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Paik, K.Y., Chung, J.C. Reappraisal of clinical indication regarding total pancreatectomy: can we do it for the risky gland?. Langenbecks Arch Surg 406, 1903–1908 (2021). https://doi.org/10.1007/s00423-021-02208-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-021-02208-7

Keywords

Navigation